GlassScriptPhysician profile
Emilee Morris
NPI 1366158446
$437.05
in general payments reported to CMS, 2019-2025
15 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $102 · 2024: $153 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $100.06 | 2023-2025 | Dupixent |
| Ironshore Pharmaceuticals INC. | $58.43 | 2023-2024 | Jornay Pm |
| Pfizer INC. | $35.35 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $27.87 | 2023 | M-M-R II, Gardasil 9, Proquad |
| Corium, LLC | $27.57 | 2024 | Azstarys |
| Sanofi Pasteur INC. | $24.49 | 2025 | |
| Acadia Pharmaceuticals INC | $22.10 | 2024 | Daybue |
| Ars Pharmaceuticals Operations, INC. | $21.82 | 2025 | Neffy |
| Janssen Biotech, INC. | $21.79 | 2025 | Carvykti |
| Nestle Healthcare Nutrition INC. | $18.31 | 2023 | |
| Seqirus USA INC | $17.50 | 2025 | Flucelvax |
| Verrica Pharmaceuticals INC. | $16.99 | 2024 | Ycanth |
| Csl Behring | $16.15 | 2025 | Andembry |
| Daiichi Sankyo INC. | $14.71 | 2025 | Vanflyta |
| Novartis Pharmaceuticals Corporation | $13.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilee Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.